Correlation analysis of targeted proteins and metabolites to assess and engineer microbial isopentenol production

Biotechnology and Bioengineering

Volumn 111, Issue 8, 2014, Pages 1648-1658

  George, Kevin W ^a,b   Chen, Amy ^a,c   Jain, Aakriti ^a,d   Batth, Tanveer S ^a,b   Baidoo, Edward E K ^a,b   Wang, George ^a,b   Adams, Paul D ^a,b,c   Petzold, Christopher J ^a,b   Keasling, Jay D ^a,b,c,d   Lee, Taek Soon ^a,b  

^a JOINT BIOENERGY INSTITUTE   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c University of California at Berkeley   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biofuel; Correlation analysis; Isopentenol; Isoprenoid; Metabolic engineering; Proteomics

Indexed keywords

BIOFUELS; CORRELATION METHODS; METABOLIC ENGINEERING; METABOLITES; MOLECULAR BIOLOGY;

CORRELATION ANALYSIS; ISOPENTENOL; ISOPRENOIDS; MICROBIAL PRODUCTION; PATHWAY ANALYSIS; PROTEOMICS; TARGETED PROTEINS; THEORETICAL YIELD;

PROTEINS;

ACETIC ACID; BIOFUEL; GLUCOSE; ISOPENTENOL; MEVALONIC ACID; UNCLASSIFIED DRUG; ACETIC ACID DERIVATIVE; ESCHERICHIA COLI PROTEIN; PENTANOL;

ARTICLE; BIOFUEL PRODUCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; METABOLIC ENGINEERING; NONHUMAN; PROTEIN TARGETING; BIOLOGICAL MODEL; BIOSYNTHESIS; ESCHERICHIA COLI; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PROCEDURES; PROTEOMICS;

ACETATES; BIOFUELS; BIOSYNTHETIC PATHWAYS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GLUCOSE; INDUSTRIAL MICROBIOLOGY; METABOLIC ENGINEERING; MODELS, BIOLOGICAL; PENTANOLS; PROTEOMICS;

EID: 84903144112     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25226     Document Type: Article

References (32)

1. Ajikumar PK, Xiao W-H, Tyo KEJ, Wang Y, Simeon F, Leonard E, Mucha O, Phon TH, Pfeifer B, Stephanopoulos G. 2010. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 330:70-74.
2. Amann E, Ochs B, Abel KJ. 1988. Tightly regulated Tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli. Gene 69:301-315.
3. Anderson JC, Dueber JE, Leguia M, Wu GC, Goler JA, Arkin AP, Keasling JD. 2010. BglBricks: A flexible standard for biological part assembly. J Biol Eng 4:1.
4. Atsumi S, Hanai T, Liao JC. 2008. Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels. Nature 451:86-89.
5. Batth TS, Keasling JD, Petzold CJ. 2012. Targeted proteomics for metabolic pathway optimization. Methods Mol Biol 944:237-249.
6. Boyle PM, Silver PA. 2012. Parts plus pipes: Synthetic biology approaches to metabolic engineering. Metab Eng 14:223-232.
7. Chou HH, Keasling JD. 2012. Synthetic pathway for production of five-carbon alcohols from isopentenyl diphosphate. Appl Environ Microbiol 78:7849-7855.
8. De Mey M, De Maeseneire S, Soetaert W, Vandamme E. 2007. Minimizing acetate formation in E. coli fermentations. J Ind Microbiol Biotechnol 34:689-700.
9. Dellomonaco C, Clomburg JM, Miller EN, Gonzalez R. 2011. Engineered reversal of the beta-oxidation cycle for the synthesis of fuels and chemicals. Nature 476:355-359.
10. Duncombe GR, Frerman FE. 1976. Molecular and catalytic properties of the acetoacetyl-coenzyme A thiolase of Escherichia coli. Arch Biochem Biophys 176:159-170.
11. Engler C, Kandzia R, Marillonnet S. 2008. A one pot, one step, precision cloning method with high throughput capability. PLoS ONE 3:e3647.
12. Engler C, Marillonnet S. 2011. Generation of families of construct variants using golden gate shuffling. Methods Mol Biol 729:167-181.
13. Kamm B, Kamm M. 2004. Principles of biorefineries. Appl Microbiol Biotechnol 64:137-145.
14. Keasling JD. 2010. Manufacturing molecules through metabolic engineering. Science 330:1355-1358.
15. Lange V, Picotti P, Domon B, Aebersold R. 2008. Selected reaction monitoring for quantitative proteomics: A tutorial. Mol Syst Biol 4:222.
16. Lee TS, Krupa RA, Zhang F, Hajimorad M, Holtz WJ, Prasad N, Lee SK, Keasling JD. 2011. BglBrick vectors and datasheets: A synthetic biology platform for gene expression. J Biol Eng 5:12.
17. Ma SM, Garcia DE, Redding-Johanson AM, Friedland GD, Chan R, Batth TS, Haliburton JR, Chivian D, Keasling JD, Petzold CJ, Lee TS, Chhabra SR. 2011. Optimization of a heterologous mevalonate pathway through the use of variant HMG-CoA reductases. Metab Eng 13:588-597.
18. Martin CH, Dhamankar H, Tseng HC, Sheppard MJ, Reisch CR, Prather KL. 2013. A platform pathway for production of 3-hydroxyacids provides a biosynthetic route to 3-hydroxy-gamma-butyrolactone. Nat Commun 4:1414.
19. Martin VJ, Pitera DJ, Withers ST, Newman JD, Keasling JD. 2003. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol 21:796-802.
20. Mukhopadhyay A, Redding AM, Rutherford BJ, Keasling JD. 2008. Importance of systems biology in engineering microbes for biofuel production. Curr Opin Biotechnol 19:228-234.
21. Mutalik VK, Guimaraes JC, Cambray G, Lam C, Christoffersen MJ, Mai Q-A, Tran AB, Paull M, Keasling JD, Arkin AP, Endy D. 2013. Precise and reliable gene expression via standard transcription and translation initiation elements. Nat Methods 10:354-360.
22. Myers JL, Well AD. 2003. Research design and statistical analysis. 2nd edition. Mahwah, NJ: Lawrence Erlbaum Associates.
23. Peralta-Yahya PP, Ouellet M, Chan R, Mukhopadhyay A, Keasling JD, Lee TS. 2011. Identification and microbial production of a terpene-based advanced biofuel. Nat Commun 2:483.
24. Quan J, Tian J. 2011. Circular polymerase extension cloning for high-throughput cloning of complex and combinatorial DNA libraries. Nat Protoc 6:242-251.
25. Redding-Johanson AM, Batth TS, Chan R, Krupa R, Szmidt HL, Adams PD, Keasling JD, Lee TS, Mukhopadhyay A, Petzold CJ. 2011. Targeted proteomics for metabolic pathway optimization: Application to terpene production. Metab Eng 13:194-203.
26. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, Chang MC, Withers ST, Shiba Y, Sarpong R, Keasling JD. 2006. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440:940-943.
27. Sivy TL, Fall R, Rosenstiel TN. 2011. Evidence of isoprenoid precursor toxicity in Bacillus subtilis. Biosci Biotechnol Biochem 75:2376-2383.
28. Withers ST, Gottlieb SS, Lieu B, Newman JD, Keasling JD. 2007. Identification of isopentenol biosynthetic genes from Bacillus subtilis by a screening method based on isoprenoid precursor toxicity. Appl Environ Microbiol 73:6277-6283.
29. Wolfe AJ. 2005. The acetate switch. Microbiol Mol Biol Rev 69:12-50.
30. Yadav VG, De Mey M, Lim CG, Ajikumar PK, Stephanopoulos G. 2012. The future of metabolic engineering and synthetic biology: Towards a systematic practice. Metab Eng 14:233-241.
31. Yim H, Haselbeck R, Niu W, Pujol-Baxley C, Burgard A, Boldt J, Khandurina J, Trawick JD, Osterhout RE, Stephen R, Estadilla J, Teisan S, Schreyer HB, Andrae S, Yang TH, Lee SY, Burk MJ, Van Dien S. 2011. Metabolic engineering of Escherichia coli for direct production of 1, 4-butanediol. Nat Chem Biol 7:445-452.
32. Zheng Y, Liu Q, Li L, Qin W, Yang J, Zhang H, Jiang X, Cheng T, Liu W, Xu X, Xian M. 2013. Metabolic engineering of Escherichia coli for high-specificity production of isoprenol and prenol as next generation of biofuels. Biotechnol Biofuels 6:57.